Published in Infect Immun on November 01, 1980
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev (1983) 7.16
Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp. Infect Immun (1986) 3.87
Outer membrane proteins of Brucella abortus: isolation and characterization. Infect Immun (1982) 3.07
Surface localization of Pseudomonas aeruginosa outer membrane porin protein F by using monoclonal antibodies. Infect Immun (1983) 2.51
Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun (1984) 1.75
Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. J Clin Microbiol (1991) 1.73
HeLa cell invasiveness and O antigen of Shigella flexneri as separate and prerequisite attributes of virulence to evoke keratoconjunctivitis in guinea pigs. Infect Immun (1983) 1.55
Comparison of sodium dodecyl sulfate-polyacrylamide gel electrophoresis profiles and antigenic relatedness among outer membrane proteins of 49 Brucella abortus strains. Infect Immun (1984) 1.40
Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains. Infect Immun (1991) 1.34
Immunogenicity of Pseudomonas aeruginosa outer membrane antigens examined by crossed immunoelectrophoresis. Infect Immun (1983) 1.33
Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12,d, Vi. Infect Immun (1988) 1.33
Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases. Emerg Infect Dis (1999) 1.29
Congo red binding and salt aggregation as indicators of virulence in Shigella species. J Clin Microbiol (1988) 1.24
Progress and pitfalls in Shigella vaccine research. Nat Rev Gastroenterol Hepatol (2013) 1.13
Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine. Infect Immun (2000) 1.05
Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei. J Clin Microbiol (1992) 1.02
Isolation and antigenic reactivity of Brucella ovis outer membrane proteins. J Clin Microbiol (1987) 0.85
Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine. Infect Immun (1991) 0.83
Purification, pore-forming ability, and antigenic relatedness of the major outer membrane protein of Shigella dysenteriae type 1. Infect Immun (1994) 0.82
Immunoproteome analysis of soluble and membrane proteins of Shigella flexneri 2457T. World J Gastroenterol (2006) 0.81
Shigella flexneri 3a outer membrane protein C epitope is recognized by human umbilical cord sera and associated with protective activity. PLoS One (2013) 0.77
An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype. PLoS Negl Trop Dis (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Outer membrane proteins of Escherichia coli. 3. Evidence that the major protein of Escherichia coli O111 outer membrane consists of four distinct polypeptide species. J Bacteriol (1974) 6.03
[Not Available]. Acta Microbiol Acad Sci Hung (1957) 5.53
Protection of Monkeys Against Experimental Shigellosis with Attenuated Vaccines. J Bacteriol (1965) 2.93
Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines. Bull World Health Organ (1968) 2.68
Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains. Bull World Health Organ (1971) 1.84
Sepharose gel filtration method of purification of lipopolysaccharides. Anal Biochem (1970) 1.24
Acquired natural immunity following recovery from keratoconjunctivitis shigellosa. J Hyg Epidemiol Microbiol Immunol (1959) 1.09
Studies on virulence of Shigella flexneri. Arch Immunol Ther Exp (Warsz) (1978) 0.98
Isolation, purification and physico-chemical characteristic of Shigella sonnei phase I free endotoxin. Eur J Biochem (1970) 0.93
A new method for the measurement of protective potency of dysentery vaccines. Acta Microbiol Acad Sci Hung (1962) 0.91
Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin. Acta Microbiol Acad Sci Hung (1974) 0.90
Inhibition with simple sugars of hemagglutination of red cells modified with Salmonella antigens. J Immunol (1962) 0.85
A study of some questions of pathogenicity and immunity in dysentery using experimental models of Shigella keratoconjunctivitis in guinea pigs. J Hyg Epidemiol Microbiol Immunol (1957) 0.84
Structure and biology of Shigella flexneri O antigens. J Med Microbiol (1987) 2.01
NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology (2010) 1.88
Pyrrolidonyl peptidase in bacteria: a new colorimetric test for differentiation of enterobacteriaceae. J Gen Microbiol (1970) 1.46
Structural studies of Shigella flexneri O-antigens. Eur J Biochem (1978) 1.43
A new type of thermoalkalophilic hydrolase of Paucimonas lemoignei with high specificity for amorphous polyesters of short chain-length hydroxyalkanoic acids. J Biol Chem (2001) 1.39
Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci U S A (1995) 1.35
Serologic relationship of fimbriae among Enterobacteriaceae. Arch Immunol Ther Exp (Warsz) (1977) 1.32
Sepharose gel filtration method of purification of lipopolysaccharides. Anal Biochem (1970) 1.24
Structural studies of the Shigella flexneri variant X, type 5 a and type 5 b O-antigens. Eur J Biochem (1977) 1.24
Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol (1997) 1.22
The core structure of Shigella sonnei lipopolysaccharide and the linkage between O-specific polysaccharide and the core region. Eur J Biochem (1982) 1.15
The enterobacterial common-antigen, a cyclic polysaccharide. Carbohydr Res (1984) 1.15
Pyrrolidonyl peptidase in bacteria. The enzyme from Bacillus subtilis. Eur J Biochem (1969) 1.12
Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol (1998) 1.12
Bacteriophage therapy of bacterial infections: an update of our institute's experience. Arch Immunol Ther Exp (Warsz) (2000) 1.11
Enterobacterial common antigen: isolation from Shigella sonnei, purification and immunochemical characterization. Eur J Biochem (1978) 1.08
Paraneoplastic vitelliform retinopathy associated with cutaneous or uveal melanoma and metastases. Klin Monbl Augenheilkd (2005) 1.07
Alligator rhodopsin: sequence and biochemical properties. Exp Eye Res (1995) 1.07
Biological properties of lipid A from Shigella sonnei. Eur J Biochem (1974) 1.04
The structure of the sialic acid-containing Escherichia coli O104 O-specific polysaccharide and its linkage to the core region in lipopolysaccharide. Carbohydr Res (1992) 1.01
Studies on virulence of Shigella flexneri. Arch Immunol Ther Exp (Warsz) (1978) 0.98
Location of O-acetyl groups in the Shigella flexneri types 3c and 4b lipopolysaccharides. Acta Chem Scand (1972) 0.97
Immunochemical studies on sialic acid-containing lipopolysaccharides from enterobacterial species. FEMS Microbiol Immunol (1992) 0.96
Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy. Arch Ophthalmol (1998) 0.96
Structural studies on Shigella flexneri serotype 6 core region. Eur J Biochem (1980) 0.94
Recoverin: a potent uveitogen for the induction of photoreceptor degeneration in Lewis rats. Exp Eye Res (1994) 0.94
Isolation, purification and physico-chemical characteristic of Shigella sonnei phase I free endotoxin. Eur J Biochem (1970) 0.93
Retinal anti-bipolar cell antibodies in a patient with paraneoplastic retinopathy and colon carcinoma. Am J Ophthalmol (2001) 0.93
Chemical studies on Shigella sonnei lipid A. Eur J Biochem (1974) 0.91
The chemical nature of Shigella flexneri group antigen factor 6. Pathol Microbiol (Basel) (1971) 0.91
Binding pattern of anti-rhodopsin monoclonal antibodies to photoreceptor cells: an immunocytochemical study. Exp Eye Res (1989) 0.90
Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin. Acta Microbiol Acad Sci Hung (1974) 0.90
Structural and serological studies on Hafnia alvei O-specific polysaccharide of alpha-D-mannan type isolated from the lipopolysaccharide of strain PCM 1223. FEMS Immunol Med Microbiol (2001) 0.89
Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch Immunol Ther Exp (Warsz) (2000) 0.89
Rod cell-specific antigens in retinoblastoma. Arch Ophthalmol (1989) 0.88
Pyrrolidonyl peptidase activity: a simple test for differentiating staphylococci. J Gen Microbiol (1972) 0.88
Hemagglutinating properties of Shigella bacilli. Arch Immunol Ther Exp (Warsz) (1967) 0.88
Rhodopsin's amino terminus is a principal antigenic site. Exp Eye Res (1986) 0.87
Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transplant Proc (2003) 0.87
Effect of proteins on the immunogenicity of enterobacterial common antigen. Infect Immun (1981) 0.87
The role of T cells in autoimmune uveitis. Ocul Immunol Inflamm (2000) 0.87
Recoverin expression in the R28 retinal precursor cell line. In Vitro Cell Dev Biol Anim (1997) 0.85
Characterization and diagnostic application of a lipopolysaccharide core oligosaccharide-protein conjugate. J Immunol Methods (1986) 0.85
Concerning the classification of Shigella flexneri 6 bacilli. Arch Immunol Ther Exp (Warsz) (1967) 0.85
Molecular, enzymatic and functional properties of rhodopsin kinase from rat pineal gland. Vision Res (1990) 0.84
[Successful treatment with bacteriophage in purulent cerebrospinal meningitis in a newborn]. Neurol Neurochir Pol (1999) 0.84
Immunochemical studies of the lipopolysaccharide O-specific polysaccharide of Hafnia alvei PCM 1199 related to H. alvei PCM 1205. Eur J Biochem (1998) 0.83
Limitation of C3-CAM shift in the common ice plant under high irradiance. J Plant Physiol (2012) 0.82
Serum antibodies to retinal antigens in lung cancer and sarcoidosis. Pathobiology (2004) 0.82
Chemical studies on the specific fragment of Shigella sonnei phase II. Eur J Biochem (1968) 0.82
Studies on gamma-glutamyl peptidase from Pseudomonas aeruginosa. Arch Immunol Ther Exp (Warsz) (1970) 0.81
Hafnia alvei lipopolysaccharides: isolation, sugar composition and SDS-PAGE analysis. FEMS Microbiol Immunol (1988) 0.80
The structure of the O-specific polysaccharide from Hafnia alvei strain 38 lipopolysaccharide. Carbohydr Res (1992) 0.80
Lipopolysaccharide core region of Hafnia alvei: serological characterization. FEMS Immunol Med Microbiol (1995) 0.80
A reliable two-dimensional gel electrophoresis procedure for separating neural proteins. Electrophoresis (1991) 0.80
Interval mapping of quantitative trait loci controlling humoral immunity to exogenous antigens: evidence that non-MHC immune response genes may also influence susceptibility to autoimmunity. J Immunol (1996) 0.80
Glycyl peptidase in human serum and tissues. FEBS Lett (1969) 0.79
Purification and primary structure of Capl, an S-100-related calcium-binding protein isolated from bovine retina. J Biol Chem (1994) 0.79
Serological analysis of core oligosaccharides of Shigella flexneri serotype 6 and its R mutants lipopolysaccharides. Arch Immunol Ther Exp (Warsz) (1981) 0.79
Early expression and localization of rhodopsin and interphotoreceptor retinoid-binding protein (IRBP) in the developing fetal bovine retina. Exp Eye Res (1992) 0.79
2-Amino-2-deoxyhexuronic acid: a constituent of Shigella sonnei phase I lipopolysaccharide. Eur J Biochem (1973) 0.79
[Molecular mimicry of bacterial polysaccharides and their role in etiology of infectious and autoimmune diseases]. Postepy Hig Med Dosw (2001) 0.79
Structural and serological studies of lipopolysaccharides of Citrobacter O35 and O38 antigenically related to Salmonella. FEMS Immunol Med Microbiol (1996) 0.79
The structure of a glycerol teichoic acid-like O-specific polysaccharide of Hafnia alvei 1205. Carbohydr Res (1992) 0.78
Calcium binding to recoverin: implications for secondary structure and membrane association. Biochim Biophys Acta (1997) 0.78
The structure of a core oligosaccharide component from Hafnia alvei strain 32 and 1192 lipopolysaccharides. Carbohydr Res (1994) 0.78
Use of a new phage preparation in prophylaxis and treatment of shigellosis. Acta Microbiol Acad Sci Hung (1974) 0.78
3-Deoxy-octulosonic-acid-containing hexasaccharide fragment of unusual core type isolated from Hafnia alvei 2 lipopolysaccharide. Eur J Biochem (1995) 0.78
Synthesis of poly(2-methyl-3-hydroxyoctanoate) via anionic polymerization of alpha-methyl-beta-pentyl-beta-propiolactone. Biomacromolecules (2001) 0.77
Protective properties of peptidoglycan associated protein of Shigella flexneri. Arch Immunol Ther Exp (Warsz) (1984) 0.77
Transfer of immunity by means of spleen cells from mice immunized with outer membrane proteins of Shigella flexneri. Arch Immunol Ther Exp (Warsz) (1985) 0.77
Enterobacterial common antigen-tetanus toxoid conjugate as immunogen. Infect Immun (1983) 0.77
Core region of Citrobacter lipopolysaccharide from strain PCM 1487. Structure elucidation by two-dimensional 1H-NMR spectroscopy at 500 MHz and methylation analysis/mass spectrometry. Eur J Biochem (1986) 0.77
Characterization of an enterobacterial common antigen (ECA) epitope recognized by anti-ECA-tetanus toxoid conjugate serum. FEMS Microbiol Lett (1991) 0.77
Detection of common polysaccharide antigen of Pseudomonas aeruginosa with O-antiserum to Pseudomonas cerasi. FEMS Microbiol Immunol (1991) 0.77
Chemical studies on the specific fragment of Shigella sonnei phase I. Biochim Biophys Acta (1967) 0.77
Phagocytic and bactericidal properties of macrophages of mice immunized with outer membrane proteins (OMP) of Shigella. Arch Immunol Ther Exp (Warsz) (1988) 0.77
Outer membrane proteins of Shigella sonnei. II. Comparative studies on virulent and avirulent strains of phase I. Arch Immunol Ther Exp (Warsz) (1980) 0.77
Structure of the O-specific polysaccharide of Hafnia alvei PCM 1222 containing 2-aminoethyl phosphate. Carbohydr Res (1996) 0.77
Novel synthesis of functionalized poly(3-hydroxybutanoic acid) and its copolymers. Int J Biol Macromol (1999) 0.77
Studies on specificity of protection induced by immunization with outer membrane proteins of Shigella. Arch Immunol Ther Exp (Warsz) (1985) 0.77
Structure of the O-specific polysaccharide of Hafnia alvei PCM 1196. Carbohydr Res (2001) 0.77
Metal transport and homeostasis within the human body: toxicity associated with transport abnormalities. Curr Med Chem (2012) 0.77
Toll-like receptor gene polymorphism and its relationship with somatic cell concentration and natural bacterial infections of the mammary gland in sheep. Folia Microbiol (Praha) (2006) 0.77